Some patients continued treatment after their cancer progressed, even though symptom-focused supportive care would have been preferable. The review found some patients continued chemotherapy after their cancer progressed, when supportive care to address their symptoms would have been a better option.
According to BBC, In one case, a patient of Prof Ian Brown received more than 100 chemotherapy cycles over 13 years and later developed leukaemia as a treatment side-effect. According to The Guardian, Becky Jones received more than 100 chemotherapy cycles over 10 years after being diagnosed with grade-4 glioblastoma and told she had six to 12 months to live.
According to The Guardian, Jones said the report’s confirmation of serious failings was validating but painful, and that she needed a full and honest explanation of what happened to her. The BBC reported that Brabners said cases had been referred to police, but no action had yet been taken.
According to BBC, the review warned that prolonged non-standard chemotherapy exposed patients to significant lifetime risk of secondary cancers and other health problems. The BBC described one patient’s significant toxicity after 10 years of treatment, including ongoing fatigue, nausea, ophthalmic shingles and galactorrhoea linked to anti-nausea medication.
The BBC reported that some patients were explicitly or implicitly told stopping treatment would be harmful, and that some received misleading information. The trust confirmed Edwards had retired and said it made a formal regulatory referral about him to the Nursing and Midwifery Council.
According to The Guardian, the RCP recommended that the trust ensure all living patients treated with more than 12 TMZ cycles had received an independent review. The BBC said the trust had begun discussions with NHS England’s regional patient-safety director about reviewing deceased patients who received non-standard chemotherapy.
According to BBC, the RCP said reviewing the deceased cohort could be a significant, costly undertaking and advised the trust to discuss whether and how to proceed with the Department of Health and Social Care or NHS England.
Reader comments (0)
Bring evidence, ask questions, or challenge our reporting. Every comment is checked before publication.
No approved comments yet
Be the first to ask a thoughtful question or contribute useful context. We won't invent reader conversations.
Join the discussion
Members-only commenting
Everyone can read comments. To write, verify your email and sign in to your free member account.
Sign in or join freeNo newsletter subscription is required. Your email address remains private.